SCHEMBL6638697

SCHEMBL6638697

COc1cc(N)ccc1OC(C)C1CCNCC1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 9/20 0.44
SLC6A4 P31645 9/20 0.44
SLC6A3 Q01959 7/20 0.44
CYP2D6 P10635 2/20 0.44
GAA P10253 2/20 0.42
MAPT P10636 2/20 0.42
KDM4E B2RXH2 2/20 0.42
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
HTR2C P28335 2/20 0.38
NR4A1 P22736 1/20 0.38
TLR9 Q9NR96 1/20 0.37
TLR8 Q9NR97 1/20 0.37
TLR7 Q9NYK1 1/20 0.37
JAK2 O60674 1/20 0.37
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4371991 0.83 SLC6A4 (0.48) SLC6A2SLC6A4SLC6A3
SCHEMBL446532 0.81 JAK2 (0.36) SLC6A2SLC6A4SLC6A3GAAJAK2
SCHEMBL8791343 0.80 ALOX15 (0.41) SLC6A2SLC6A4SLC6A3CYP2D6MAPK1
SCHEMBL4929501 0.80 SLC6A4 (0.41) SLC6A2SLC6A4SLC6A3GAATSHR
SCHEMBL7469675 0.79 CA12 (0.55) SLC6A2SLC6A4SLC6A3CYP2D6TSHR
SCHEMBL2371617 0.78 MAPT (0.55) GAAMAPTKDM4ETSHRMAPK1
SCHEMBL15650817 0.78 PDE4B (0.48) SLC6A2SLC6A4SLC6A3GAAMAPT
SCHEMBL444816 0.78 SLC6A4 (0.35) SLC6A2SLC6A4SLC6A3HTR2CJAK2
SCHEMBL6619157 0.78 SLC6A2 (0.41) SLC6A2SLC6A4SLC6A3CYP2D6KDM4E
SCHEMBL2031773 0.75 ALDH1A1 (0.45) SLC6A2SLC6A4SLC6A3HTR2CJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1427421-A1 2,4-DISUBSTITUTED PYRIMIDINYL DERIVATIVES FOR USE AS ANTICANCER AGENTS Amgen Inc. (US) 2004-06-16 EP disclosed
WO-2003018021-A1 2,4-DISUBSTITUTED PYRIMIDINYL DERIVATIVES FOR USE AS ANTICANCER AGENTS AMGEN INC. (US) 2003-03-06 WO disclosed